in view of the immunogenicity of both mel 1 and the ah antigens in humans and their occurrence on more than 50 % of melanomas , it remains to be seen whether antibody to these antigens can be elicited by specific vaccination of seronegative melanoma patients and whether this will have an influence on the clinical course of the disease .
C0300061
ah antigens
C0086418
humans